These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23594983)

  • 1. [Adherence to and satisfaction with oral outpatient thromboembolism prophylaxis compared to parenteral: SALTO study].
    Peidro-Garcés L; Otero-Fernandez R; Lozano-Lizarraga L
    Rev Esp Cir Ortop Traumatol; 2013; 57(1):53-60. PubMed ID: 23594983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
    Plumb JM; Clemens A; Monz BU
    Pharmacoeconomics; 2010; 28(9):781-2; author reply 782-4, 784-5. PubMed ID: 20824908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].
    Gómez Arrayas I; Suárez Fernández C; Gómez Cerezo JF; Betegón Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Salud Publica; 2012 Dec; 86(6):601-12. PubMed ID: 23325135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].
    Guijarro Merino R; Villalobos Sánchez A
    Med Clin (Barc); 2012 Oct; 139 Suppl 2():13-8. PubMed ID: 23498067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
    Monreal M; Folkerts K; Diamantopoulos A; Imberti D; Brosa M
    Thromb Haemost; 2013 Nov; 110(5):987-94. PubMed ID: 23965805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
    Huisman MV; Quinlan DJ; Dahl OE; Schulman S
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study.
    Lazo-Langner A; Fleet JL; McArthur E; Garg AX
    J Thromb Haemost; 2014 Oct; 12(10):1626-35. PubMed ID: 25069387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.
    Fisher WD
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S15-21. PubMed ID: 21517651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients.
    Riva N; Donadini MP; Bozzato S; Ageno W
    Thromb Res; 2013 Jan; 131 Suppl 1():S67-70. PubMed ID: 23452747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New oral anticoagulants--a review.
    Ghanima W; Atar D; Sandset PM
    Tidsskr Nor Laegeforen; 2013 Oct; 133(18):1940-5. PubMed ID: 24084970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey.
    Rogers BA; Phillips S; Foote J; Drabu KJ
    Ann R Coll Surg Engl; 2010 Nov; 92(8):668-72. PubMed ID: 20615303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].
    Gómez-Cerezo JF; Gómez-Arrayás I; Suárez-Fernández C; Betegón-Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Cir Ortop Traumatol; 2012; 56(6):459-70. PubMed ID: 23594943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
    Lereun C; Wells P; Diamantopoulos A; Rasul F; Lees M; Sengupta N
    J Med Econ; 2011; 14(2):238-44. PubMed ID: 21385145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New anticoagulants as thromboprophylaxis after total hip or knee replacement.
    Hamidi V; Ringerike T; Hagen G; Reikvam Å; Klemp M
    Int J Technol Assess Health Care; 2013 Jul; 29(3):234-43. PubMed ID: 23768996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaesthesia and thromboembolic disease].
    Llau JV; Sapena ML; López Forte C; Ferrandis R
    Med Clin (Barc); 2008 Nov; 131 Suppl 2():42-7. PubMed ID: 19087850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
    Mrozik D; Jackiewicz A; Krzemiński M
    Pol Orthop Traumatol; 2012 Oct; 77():111-4. PubMed ID: 23306297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
    Galanis T; Kraft WK; Merli GJ
    Adv Surg; 2011; 45():361-90. PubMed ID: 21954699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.